
TherapeuticsMD, Inc. — Investor Relations & Filings
TherapeuticsMD, Inc. is a pharmaceutical company exclusively focused on advancing women's health. The company operates as a royalty-based entity, licensing its portfolio of differentiated women's health products to pharmaceutical organizations. Through exclusive licensing partnerships in the United States and internationally, TherapeuticsMD receives royalties on the sales of its products, which are designed to address unmet medical needs for women.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| QUARTERLY REPORT | 2026-05-12 | English | |
| CURRENT REPORT | 2026-05-12 | English | |
| Major Shareholding Notification 2026 | 2026-04-07 | English | |
| ANNUAL REPORT | 2026-04-01 | English | |
| NOTIFICATION OF LATE FILING | 2026-04-01 | English | |
| CURRENT REPORT | 2026-03-30 | English |
Browse filings by year
27 years- 2026 8 filings
- 2025 28 filings
- 2024 18 filings
- 2023 47 filings
- 2022 92 filings
- 2021 83 filings
- 2020 73 filings
- 2019 77 filings
- 2018 94 filings
- 2017 59 filings
- 2016 42 filings
- 2015 77 filings
- 2014 71 filings
- 2013 70 filings
- 2012 61 filings
- 2011 38 filings
- 2010 22 filings
- 2009 25 filings
- 2008 18 filings
- 2007 35 filings
- 2006 14 filings
- 2005 36 filings
- 2004 21 filings
- 2003 8 filings
- 2002 11 filings
- 2001 5 filings
- 2000 5 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
8 filings
| |||||
| 45913523 | QUARTERLY REPORT | 2026-05-12 | English | ||
| 45913537 | CURRENT REPORT | 2026-05-12 | English | ||
| 45913544 | Major Shareholding Notification 2026 | 2026-04-07 | English | ||
| 45913608 | ANNUAL REPORT | 2026-04-01 | English | ||
| 45913626 | NOTIFICATION OF LATE FILING | 2026-04-01 | English | ||
| 45913622 | CURRENT REPORT | 2026-03-30 | English | ||
| 33093368 | 10-K - TherapeuticsMD, Inc. (0000025743) (Filer) | 2026-03-30 | English | ||
| 32875664 | 8-K - THERAPEUTICSMD, INC. (0000025743) (Filer) | 2026-01-20 | English | ||
|
2025
7 filings
| |||||
| 15597250 | 4 Filing | 2025-12-29 | English | ||
| 15597279 | 8-K Filing | 2025-12-16 | English | ||
| 8383355 | CURRENT REPORT | 2025-11-13 | English | ||
| 8383361 | QUARTERLY REPORT | 2025-11-12 | English | ||
| 8383362 | Director's Dealing 2025 | 2025-11-05 | English | ||
| 8383363 | Director's Dealing 2025 | 2025-11-05 | English | ||
| 8383364 | Director's Dealing 2025 | 2025-11-05 | English | ||
Market data
Market data not available
Price history
Peer group · Patent brokering and marketing service activities
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Synerga Fund Spolka Akcyjna
A private equity and venture capital firm investing in bloc…
|
SNG | PL | Professional, scientific and te… |
TherapeuticsMD, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35134/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35134 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35134 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35134 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35134}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for TherapeuticsMD, Inc. (id: 35134)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.